Soleno Therapeutics, Inc. (SLNO)
43.77
+0.21
(+0.48%)
USD |
NASDAQ |
Jan 22, 16:00
43.77
0.00 (0.00%)
After-Hours: 20:00
Soleno Therapeutics EPS Diluted (Quarterly): 0.4736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.4644 |
| Agilon Health, Inc. | -0.2659 |
| Nektar Therapeutics | -1.875 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| Marker Therapeutics, Inc. | -0.1193 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.01M |
| Revenue (Quarterly) | 66.02M |
| Total Expenses (Quarterly) | 40.00M |
| Enterprise Value | 1.893B |
| Gross Profit Margin (Quarterly) | 98.27% |
| Profit Margin (Quarterly) | 39.40% |
| Earnings Yield | -4.21% |
| Normalized Earnings Yield | -4.041 |